How much does Givlaari (givosiran) cost per year?
Givlaari cost varies a lot based on dosage, treatment schedule, and how pricing is handled in a specific country and insurance system. Pricing also depends on whether you’re paying cash, using commercial insurance, Medicare/Medicaid, or manufacturer patient-assistance programs.
If you tell me your country (and whether this is for an individual, hospital, or insurance quote), I can narrow down what people typically see for out-of-pocket vs. billed cost.
What’s the typical U.S. pricing or “list price” people look for?
Many people searching “Givlaari cost” are looking for one of these:
- List price (manufacturer price before rebates/negotiated discounts)
- Average wholesale price or billing cost used in estimates
- Estimated annual cost based on the labeled dosing schedule
To give you a useful number, I need the pricing basis you want (list price vs. average/billed vs. your expected out-of-pocket).
What affects Givlaari cost the most (dose, schedule, and duration)?
For gene-silencing drugs like Givlaari, cost is driven mostly by:
- Weight-based or regimen-based dosing (how many vials are used per administration)
- How often doses are given
- How long treatment continues
- Rebates/discount arrangements between payers and the manufacturer
Those factors usually change the “per-year” estimate more than anything else.
Will insurance cover it, and what might patients pay?
Out-of-pocket cost can range from low copays to high coinsurance, depending on:
- Your formulary tier and prior authorization status
- Deductible status
- Whether your insurer requires step therapy or limits coverage
- Availability of manufacturer assistance for eligible patients
If you’re trying to budget, what info should you provide?
Reply with:
1) Your country
2) Insurance type (commercial, Medicare, Medicaid, uninsured)
3) Your approximate weight (if you want dosing-based estimates)
4) Whether you mean “annual cost,” “per injection cost,” or “what I’ll pay”
Sources: None provided.